1. Williams G, Pickup JC. Handbook of Diabetes. 2nd ed.London, England: Blackwell Science; 1999.
2.
2. UK Prospective Diabetes Study (UKPDS) Group. Xintensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352:837-853.
3.
3. Da Costa S.A co-ordinated approach to insulin transfer in the older, type 2 patient. J Diabetes Nurs. 1997;1:123-126.
4.
4. Market research data. Indianapolis, Ind: Eli Lilly & Co; 2000.
5.
5. Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus vial and syringe. Clin Ther. 1998;20:486-496.
6.
6. Ltief AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care. 1999; 22:137-140.
7.
7. Ginsberg BH, Parkes JL, Soaracino C.The kinetics of insulin administration by insulin pens. Horm Metab Res.1994;26:584-587.
8.
8. Tallroth G, Karlson B, Nilsson A, et al. The influence of different insulin regimens on quality of life and metabolic control in insulindependent diabetics. Diabetes Res Clin Pract. 1989;6:37.
9.
9. Brown H, Dempsey C.Choosing the right insulin regime for optimal control. Commun Nurse. 2000; October.
10.
10. Hicks D.Modern Diabetes Management. London, England: Medical Education Partnership. In press.
11.
11. Watkins P, ed. Diabetes and Its Management. 5th ed.London, England: Blackwell Science; 1996.
12.
12. Diabetes Control and Complications Trial Research Group. The effects of intensive treatment of diabetes on the development and progression of longterm complications in insulindependent diabetes mellitus. N Engl J Med.1983;329:977-986.